BDBM50419619 CHEMBL1940296

SMILES: CNC(=O)c1ccc(Oc2ccc(cc2)C#C[C@]2(O)CN3CCC2CC3)cc1

InChI Key: InChIKey=CWFNNQMBLVACQD-QHCPKHFHSA-N

Data: 10 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 50419619   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Matrix metalloproteinase-9 (Homo sapiens (Human))	BDBM50419619 (CHEMBL1940296) Show SMILES CNC(=O)c1ccc(Oc2ccc(cc2)C#C[C@]2(O)CN3CCC2CC3)cc1 |r,wU:17.18,wD:17.17,(18.36,-56.75,;19.7,-57.53,;21.04,-56.76,;21.04,-55.22,;22.37,-57.54,;23.71,-56.78,;25.04,-57.55,;25.03,-59.09,;26.36,-59.87,;27.7,-59.11,;27.71,-57.56,;29.05,-56.8,;30.38,-57.59,;30.37,-59.12,;29.04,-59.88,;31.72,-56.83,;33.06,-56.07,;34.37,-55.28,;34.35,-56.8,;34.34,-53.75,;35.66,-52.97,;37.78,-53.4,;37.82,-55.58,;35.69,-56.02,;36.98,-55.24,;36.97,-53.74,;23.7,-59.86,;22.37,-59.09,)| Show InChI InChI=1S/C23H24N2O3/c1-24-22(26)18-4-8-21(9-5-18)28-20-6-2-17(3-7-20)10-13-23(27)16-25-14-11-19(23)12-15-25/h2-9,19,27H,11-12,14-16H2,1H3,(H,24,26)/t23-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	<1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of MMP9 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis				Bioorg Med Chem Lett 22: 271-7 (2011) Article DOI: 10.1016/j.bmcl.2011.11.034 BindingDB Entry DOI: 10.7270/Q20R9PTN
					More data for this Ligand-Target Pair
Cytochrome P450 3A4 (Homo sapiens (Human))	BDBM50419619 (CHEMBL1940296) Show SMILES CNC(=O)c1ccc(Oc2ccc(cc2)C#C[C@]2(O)CN3CCC2CC3)cc1 |r,wU:17.18,wD:17.17,(18.36,-56.75,;19.7,-57.53,;21.04,-56.76,;21.04,-55.22,;22.37,-57.54,;23.71,-56.78,;25.04,-57.55,;25.03,-59.09,;26.36,-59.87,;27.7,-59.11,;27.71,-57.56,;29.05,-56.8,;30.38,-57.59,;30.37,-59.12,;29.04,-59.88,;31.72,-56.83,;33.06,-56.07,;34.37,-55.28,;34.35,-56.8,;34.34,-53.75,;35.66,-52.97,;37.78,-53.4,;37.82,-55.58,;35.69,-56.02,;36.98,-55.24,;36.97,-53.74,;23.7,-59.86,;22.37,-59.09,)| Show InChI InChI=1S/C23H24N2O3/c1-24-22(26)18-4-8-21(9-5-18)28-20-6-2-17(3-7-20)10-13-23(27)16-25-14-11-19(23)12-15-25/h2-9,19,27H,11-12,14-16H2,1H3,(H,24,26)/t23-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	<1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of CYP3A4				Bioorg Med Chem Lett 22: 271-7 (2011) Article DOI: 10.1016/j.bmcl.2011.11.034 BindingDB Entry DOI: 10.7270/Q20R9PTN
					More data for this Ligand-Target Pair
Collagenase 3 (Homo sapiens (Human))	BDBM50419619 (CHEMBL1940296) Show SMILES CNC(=O)c1ccc(Oc2ccc(cc2)C#C[C@]2(O)CN3CCC2CC3)cc1 |r,wU:17.18,wD:17.17,(18.36,-56.75,;19.7,-57.53,;21.04,-56.76,;21.04,-55.22,;22.37,-57.54,;23.71,-56.78,;25.04,-57.55,;25.03,-59.09,;26.36,-59.87,;27.7,-59.11,;27.71,-57.56,;29.05,-56.8,;30.38,-57.59,;30.37,-59.12,;29.04,-59.88,;31.72,-56.83,;33.06,-56.07,;34.37,-55.28,;34.35,-56.8,;34.34,-53.75,;35.66,-52.97,;37.78,-53.4,;37.82,-55.58,;35.69,-56.02,;36.98,-55.24,;36.97,-53.74,;23.7,-59.86,;22.37,-59.09,)| Show InChI InChI=1S/C23H24N2O3/c1-24-22(26)18-4-8-21(9-5-18)28-20-6-2-17(3-7-20)10-13-23(27)16-25-14-11-19(23)12-15-25/h2-9,19,27H,11-12,14-16H2,1H3,(H,24,26)/t23-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	200	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis				Bioorg Med Chem Lett 22: 271-7 (2011) Article DOI: 10.1016/j.bmcl.2011.11.034 BindingDB Entry DOI: 10.7270/Q20R9PTN
					More data for this Ligand-Target Pair
72 kDa type IV collagenase (Homo sapiens (Human))	BDBM50419619 (CHEMBL1940296) Show SMILES CNC(=O)c1ccc(Oc2ccc(cc2)C#C[C@]2(O)CN3CCC2CC3)cc1 |r,wU:17.18,wD:17.17,(18.36,-56.75,;19.7,-57.53,;21.04,-56.76,;21.04,-55.22,;22.37,-57.54,;23.71,-56.78,;25.04,-57.55,;25.03,-59.09,;26.36,-59.87,;27.7,-59.11,;27.71,-57.56,;29.05,-56.8,;30.38,-57.59,;30.37,-59.12,;29.04,-59.88,;31.72,-56.83,;33.06,-56.07,;34.37,-55.28,;34.35,-56.8,;34.34,-53.75,;35.66,-52.97,;37.78,-53.4,;37.82,-55.58,;35.69,-56.02,;36.98,-55.24,;36.97,-53.74,;23.7,-59.86,;22.37,-59.09,)| Show InChI InChI=1S/C23H24N2O3/c1-24-22(26)18-4-8-21(9-5-18)28-20-6-2-17(3-7-20)10-13-23(27)16-25-14-11-19(23)12-15-25/h2-9,19,27H,11-12,14-16H2,1H3,(H,24,26)/t23-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	2.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis				Bioorg Med Chem Lett 22: 271-7 (2011) Article DOI: 10.1016/j.bmcl.2011.11.034 BindingDB Entry DOI: 10.7270/Q20R9PTN
					More data for this Ligand-Target Pair
Cytochrome P450 2C19 (Homo sapiens (Human))	BDBM50419619 (CHEMBL1940296) Show SMILES CNC(=O)c1ccc(Oc2ccc(cc2)C#C[C@]2(O)CN3CCC2CC3)cc1 |r,wU:17.18,wD:17.17,(18.36,-56.75,;19.7,-57.53,;21.04,-56.76,;21.04,-55.22,;22.37,-57.54,;23.71,-56.78,;25.04,-57.55,;25.03,-59.09,;26.36,-59.87,;27.7,-59.11,;27.71,-57.56,;29.05,-56.8,;30.38,-57.59,;30.37,-59.12,;29.04,-59.88,;31.72,-56.83,;33.06,-56.07,;34.37,-55.28,;34.35,-56.8,;34.34,-53.75,;35.66,-52.97,;37.78,-53.4,;37.82,-55.58,;35.69,-56.02,;36.98,-55.24,;36.97,-53.74,;23.7,-59.86,;22.37,-59.09,)| Show InChI InChI=1S/C23H24N2O3/c1-24-22(26)18-4-8-21(9-5-18)28-20-6-2-17(3-7-20)10-13-23(27)16-25-14-11-19(23)12-15-25/h2-9,19,27H,11-12,14-16H2,1H3,(H,24,26)/t23-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	<1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of CYP2C19				Bioorg Med Chem Lett 22: 271-7 (2011) Article DOI: 10.1016/j.bmcl.2011.11.034 BindingDB Entry DOI: 10.7270/Q20R9PTN
					More data for this Ligand-Target Pair
Cytochrome P450 1A (Homo sapiens (Human))	BDBM50419619 (CHEMBL1940296) Show SMILES CNC(=O)c1ccc(Oc2ccc(cc2)C#C[C@]2(O)CN3CCC2CC3)cc1 |r,wU:17.18,wD:17.17,(18.36,-56.75,;19.7,-57.53,;21.04,-56.76,;21.04,-55.22,;22.37,-57.54,;23.71,-56.78,;25.04,-57.55,;25.03,-59.09,;26.36,-59.87,;27.7,-59.11,;27.71,-57.56,;29.05,-56.8,;30.38,-57.59,;30.37,-59.12,;29.04,-59.88,;31.72,-56.83,;33.06,-56.07,;34.37,-55.28,;34.35,-56.8,;34.34,-53.75,;35.66,-52.97,;37.78,-53.4,;37.82,-55.58,;35.69,-56.02,;36.98,-55.24,;36.97,-53.74,;23.7,-59.86,;22.37,-59.09,)| Show InChI InChI=1S/C23H24N2O3/c1-24-22(26)18-4-8-21(9-5-18)28-20-6-2-17(3-7-20)10-13-23(27)16-25-14-11-19(23)12-15-25/h2-9,19,27H,11-12,14-16H2,1H3,(H,24,26)/t23-/m0/s1	PDB MMDB Reactome pathway KEGG B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	<1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of CYP1A2				Bioorg Med Chem Lett 22: 271-7 (2011) Article DOI: 10.1016/j.bmcl.2011.11.034 BindingDB Entry DOI: 10.7270/Q20R9PTN
					More data for this Ligand-Target Pair
Matrix metalloproteinase-14 (MMP14) (Homo sapiens (Human))	BDBM50419619 (CHEMBL1940296) Show SMILES CNC(=O)c1ccc(Oc2ccc(cc2)C#C[C@]2(O)CN3CCC2CC3)cc1 |r,wU:17.18,wD:17.17,(18.36,-56.75,;19.7,-57.53,;21.04,-56.76,;21.04,-55.22,;22.37,-57.54,;23.71,-56.78,;25.04,-57.55,;25.03,-59.09,;26.36,-59.87,;27.7,-59.11,;27.71,-57.56,;29.05,-56.8,;30.38,-57.59,;30.37,-59.12,;29.04,-59.88,;31.72,-56.83,;33.06,-56.07,;34.37,-55.28,;34.35,-56.8,;34.34,-53.75,;35.66,-52.97,;37.78,-53.4,;37.82,-55.58,;35.69,-56.02,;36.98,-55.24,;36.97,-53.74,;23.7,-59.86,;22.37,-59.09,)| Show InChI InChI=1S/C23H24N2O3/c1-24-22(26)18-4-8-21(9-5-18)28-20-6-2-17(3-7-20)10-13-23(27)16-25-14-11-19(23)12-15-25/h2-9,19,27H,11-12,14-16H2,1H3,(H,24,26)/t23-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	<1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of MMP14 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis				Bioorg Med Chem Lett 22: 271-7 (2011) Article DOI: 10.1016/j.bmcl.2011.11.034 BindingDB Entry DOI: 10.7270/Q20R9PTN
					More data for this Ligand-Target Pair
Matrix metalloproteinase-12 (MMP12) (Homo sapiens (Human))	BDBM50419619 (CHEMBL1940296) Show SMILES CNC(=O)c1ccc(Oc2ccc(cc2)C#C[C@]2(O)CN3CCC2CC3)cc1 |r,wU:17.18,wD:17.17,(18.36,-56.75,;19.7,-57.53,;21.04,-56.76,;21.04,-55.22,;22.37,-57.54,;23.71,-56.78,;25.04,-57.55,;25.03,-59.09,;26.36,-59.87,;27.7,-59.11,;27.71,-57.56,;29.05,-56.8,;30.38,-57.59,;30.37,-59.12,;29.04,-59.88,;31.72,-56.83,;33.06,-56.07,;34.37,-55.28,;34.35,-56.8,;34.34,-53.75,;35.66,-52.97,;37.78,-53.4,;37.82,-55.58,;35.69,-56.02,;36.98,-55.24,;36.97,-53.74,;23.7,-59.86,;22.37,-59.09,)| Show InChI InChI=1S/C23H24N2O3/c1-24-22(26)18-4-8-21(9-5-18)28-20-6-2-17(3-7-20)10-13-23(27)16-25-14-11-19(23)12-15-25/h2-9,19,27H,11-12,14-16H2,1H3,(H,24,26)/t23-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	<1.00E+5	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of MMP12 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis				Bioorg Med Chem Lett 22: 271-7 (2011) Article DOI: 10.1016/j.bmcl.2011.11.034 BindingDB Entry DOI: 10.7270/Q20R9PTN
					More data for this Ligand-Target Pair
Cytochrome P450 2D6 (Homo sapiens (Human))	BDBM50419619 (CHEMBL1940296) Show SMILES CNC(=O)c1ccc(Oc2ccc(cc2)C#C[C@]2(O)CN3CCC2CC3)cc1 |r,wU:17.18,wD:17.17,(18.36,-56.75,;19.7,-57.53,;21.04,-56.76,;21.04,-55.22,;22.37,-57.54,;23.71,-56.78,;25.04,-57.55,;25.03,-59.09,;26.36,-59.87,;27.7,-59.11,;27.71,-57.56,;29.05,-56.8,;30.38,-57.59,;30.37,-59.12,;29.04,-59.88,;31.72,-56.83,;33.06,-56.07,;34.37,-55.28,;34.35,-56.8,;34.34,-53.75,;35.66,-52.97,;37.78,-53.4,;37.82,-55.58,;35.69,-56.02,;36.98,-55.24,;36.97,-53.74,;23.7,-59.86,;22.37,-59.09,)| Show InChI InChI=1S/C23H24N2O3/c1-24-22(26)18-4-8-21(9-5-18)28-20-6-2-17(3-7-20)10-13-23(27)16-25-14-11-19(23)12-15-25/h2-9,19,27H,11-12,14-16H2,1H3,(H,24,26)/t23-/m0/s1	PDB UniProtKB/SwissProt UniProtKB/TrEMBL GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	<1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of CYP2D6				Bioorg Med Chem Lett 22: 271-7 (2011) Article DOI: 10.1016/j.bmcl.2011.11.034 BindingDB Entry DOI: 10.7270/Q20R9PTN
					More data for this Ligand-Target Pair
Cytochrome P450 2C9 (Homo sapiens (Human))	BDBM50419619 (CHEMBL1940296) Show SMILES CNC(=O)c1ccc(Oc2ccc(cc2)C#C[C@]2(O)CN3CCC2CC3)cc1 |r,wU:17.18,wD:17.17,(18.36,-56.75,;19.7,-57.53,;21.04,-56.76,;21.04,-55.22,;22.37,-57.54,;23.71,-56.78,;25.04,-57.55,;25.03,-59.09,;26.36,-59.87,;27.7,-59.11,;27.71,-57.56,;29.05,-56.8,;30.38,-57.59,;30.37,-59.12,;29.04,-59.88,;31.72,-56.83,;33.06,-56.07,;34.37,-55.28,;34.35,-56.8,;34.34,-53.75,;35.66,-52.97,;37.78,-53.4,;37.82,-55.58,;35.69,-56.02,;36.98,-55.24,;36.97,-53.74,;23.7,-59.86,;22.37,-59.09,)| Show InChI InChI=1S/C23H24N2O3/c1-24-22(26)18-4-8-21(9-5-18)28-20-6-2-17(3-7-20)10-13-23(27)16-25-14-11-19(23)12-15-25/h2-9,19,27H,11-12,14-16H2,1H3,(H,24,26)/t23-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	<1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of CYP2C9				Bioorg Med Chem Lett 22: 271-7 (2011) Article DOI: 10.1016/j.bmcl.2011.11.034 BindingDB Entry DOI: 10.7270/Q20R9PTN
					More data for this Ligand-Target Pair